JBIO - Jade Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.75
DETAILS
HIGH:
$45.00
LOW:
$32.00
MEDIAN:
$37.00
CONSENSUS:
$37.75
UPSIDE:
69.97%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 |
| Gross Profit | 0 | (0.3) | (0.1) | (0.1) | (0.0) | (0.0) |
| Operating Expenses | ||||||
| R&D Expenses | 93.1 | 53.2 | 64.2 | 38.6 | 15.0 | 7.9 |
| SG&A Expenses | 20.4 | 21.1 | 17.1 | 14.5 | 8.0 | 0.9 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 113.5 | 74.3 | 81.3 | 53.2 | 23.0 | 8.9 |
| Operating Income | ||||||
| Operating Income | (113.5) | (74.6) | (81.4) | (53.2) | (23.0) | (8.9) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Interest Income | 7.8 | 5.0 | 5.9 | 1.8 | 0.1 | 0 |
| Profitability | ||||||
| EBITDA | (113.5) | (69.3) | (75.4) | (51.4) | (22.9) | (9.5) |
| EBIT | (113.5) | (69.6) | (75.5) | (51.5) | (23.0) | (9.5) |
| Income Before Tax | (127.4) | (69.6) | (75.5) | (51.5) | (23.0) | (9.6) |
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0 |
| Net Income | (127.4) | (69.6) | (75.5) | (51.5) | (23.0) | (9.6) |
| Per Share Data | ||||||
| EPS (Basic) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 | -14.00 |
| EPS (Diluted) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 | -14.00 |
| Shares Outstanding | 31.4 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 88.4 | 33.8 | 23.5 | 22.4 | 54.2 | 4.6 |
| Short-Term Investments | 247.7 | 44.9 | 98.9 | 106.8 | 113.2 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0.8 | 0.2 | 0.3 | 0.2 | 0.1 |
| Total Current Assets | 336.2 | 80.1 | 124.2 | 131.5 | 174.3 | 4.7 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 0 | 0.2 | 0.9 | 1.2 | 0.7 | 0.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13.6 | 0 | 2.3 | 2.6 | 0.3 | 0 |
| Total Non-Current Assets | 13.6 | 0.2 | 3.2 | 3.8 | 1.0 | 0.0 |
| Total Assets | 349.8 | 80.3 | 127.4 | 135.3 | 175.4 | 4.7 |
| Current Liabilities | ||||||
| Account Payables | 2.2 | 0.2 | 2.4 | 2.6 | 1.2 | 0.6 |
| Short-Term Debt | 0 | 0.4 | 0.4 | 0.4 | 0.2 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.4 | 0.3 | 10.5 | 3.1 | 0.4 | 1.0 |
| Total Current Liabilities | 16.5 | 3.8 | 17.6 | 7.8 | 2.5 | 1.8 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0.1 | 0.1 | 0.1 | 0.0 | 0 |
| Total Non-Current Liabilities | 0.7 | 0.1 | 0.3 | 0.8 | 0.4 | 0 |
| Total Liabilities | 17.3 | 3.9 | 18.0 | 8.6 | 2.9 | 1.8 |
| Stockholders' Equity | ||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Retained Earnings | (174.4) | (233.1) | (163.4) | (87.9) | (36.4) | (13.4) |
| Accumulated Other Comprehensive Income | 0.1 | 0.1 | 0.2 | (0.5) | (0.1) | 0 |
| Total Stockholders' Equity | 332.5 | 76.4 | 109.5 | 126.7 | 172.4 | 2.9 |
| Total Liabilities & Equity | 349.8 | 80.3 | 127.4 | 135.3 | 175.4 | 4.7 |
| Debt Metrics | ||||||
| Total Debt | 0.7 | 0.4 | 0.7 | 1.1 | 0.6 | 0 |
| Net Debt | (87.7) | (33.3) | (22.8) | (21.3) | (53.6) | (4.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (127.4) | (69.6) | (75.5) | (51.5) | (23.0) | (9.6) |
| Depreciation & Amortization | 0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (8.2) | (11.2) | 9.8 | 7.8 | (6.5) | 1.0 |
| Other Non-Cash Items | 40.9 | 9.3 | 8.8 | 4.6 | 2.1 | 0.8 |
| Operating Cash Flow | (94.7) | (71.2) | (56.8) | (39.1) | (27.4) | (7.9) |
| Investing Activities | ||||||
| Capital Expenditure | (0.2) | 0 | (0.1) | (0.2) | (0.2) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (19.7) | (124.0) | (147.6) | (113.3) | 0 |
| Sales/Maturities of Investments | 0 | 75.7 | 136 | 154.7 | 0 | 0 |
| Other Investing Activities | (246.8) | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (247.0) | 56.0 | 11.9 | 6.9 | (113.4) | 0 |
| Financing Activities | ||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 2.5 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.2 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 360.8 | 25.4 | 46.0 | 0.4 | 190.5 | 8.9 |
| Cash Position | ||||||
| Net Change in Cash | (33.8) | 10.3 | 1.1 | (31.8) | 49.6 | 1.1 |
| Cash at Beginning | 33.8 | 23.5 | 22.4 | 54.2 | 4.6 | 3.5 |
| Cash at End | 0 | 33.8 | 23.5 | 22.4 | 54.2 | 4.6 |
| Free Cash Flow | (94.9) | (71.2) | (56.9) | (39.3) | (27.6) | (7.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | (0.3) | (0.1) | (0.1) | (0.0) | (0.0) |
| Operating Income | (113.5) | (74.6) | (81.4) | (53.2) | (23.0) | (8.9) |
| Net Income | (127.4) | (69.6) | (75.5) | (51.5) | (23.0) | (9.6) |
| EPS (Diluted) | -4.06 | -85.26 | -100.38 | -73.67 | -32.96 | -14.00 |
| Balance Sheet | ||||||
| Cash & Equivalents | 88.4 | 33.8 | 23.5 | 22.4 | 54.2 | 4.6 |
| Total Assets | 349.8 | 80.3 | 127.4 | 135.3 | 175.4 | 4.7 |
| Total Debt | 0.7 | 0.4 | 0.7 | 1.1 | 0.6 | 0 |
| Stockholders' Equity | 332.5 | 76.4 | 109.5 | 126.7 | 172.4 | 2.9 |
| Cash Flow | ||||||
| Operating Cash Flow | (94.7) | (71.2) | (56.8) | (39.1) | (27.4) | (7.9) |
| Capital Expenditure | (0.2) | 0 | (0.1) | (0.2) | (0.2) | 0 |
| Free Cash Flow | (94.9) | (71.2) | (56.9) | (39.3) | (27.6) | (7.9) |